The global therapeutic endoscopy devices market size was estimated to be USD 2.68 billion in 2023 and is expected to reach at USD 5.86 billion by 2034 with a CAGR of 7.35% during the forecast period 2024-2034. Surge in prevalence of cancer, rising technological advancements in therapeutic endoscopy devices, growing demand for minimally invasive surgeries, increasing new product launches, surge in investment in therapeutic endoscopic devices, rising launch of Robotic-Assisted Endoscopes (RAE), and increasing regulatory approvals of advanced endoscopy systems are some of the key factors boosting the market growth.
Increasing regulatory approvals of advanced endoscopy systems is predicted to boost the market growth during the forecast period. For instance, in July 2022, Zsquare, a prominent developer of high-performance disposable endoscopes, has received FDA 510K clearance for the introduction of its inaugural device, the Zsquare ENT-FlexTM Rhinolaryngoscope. Zsquare plans to initiate a trial program in leading U.S. hospitals and medical practices by the fourth quarter of 2022. Notably, the Zsquare ENT-FlexTM endoscope stands out as the first to incorporate a hybrid design, featuring an entirely disposable optical shell that encompasses a reusable imaging core.
By product, endoscope was the highest revenue-grossing segment in the global therapeutic endoscopy devices market in 2023 owing to yhe high resolution & high-quality images delivered by endoscopes for diagnosis & treatment of various diseases, rising investment for the development of technologically advanced endoscopy methods such as capsule endoscopes, duodenoscopes & echoendoscopes, and increasing approvals by regulatory bodies. For instance, in May 2023, Olympus Corporation, a global leader in developing and providing innovative solutions for medical and surgical procedures, has disclosed the FDA's clearance for their latest EVIS X1 endoscopy system and two corresponding gastrointestinal endoscopes. The GIF-1100 gastrointestinal videoscopes are recommended for examining the upper digestive tract, encompassing the esophagus, stomach, and duodenum. Additionally, endoscopy visualization systems is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for minimally invasive procedures, increasing prevalence of diseases, and surge in adoption of advanced products.
By hygiene, single use was the highest revenue-grossing segment in the global therapeutic endoscopy devices market in 2023 owing to the safety of patients has improved with the introduction of disposable endoscopes, increasing adoption of disposable products due to rising concerns regarding contamination & infections, and surge in approvals by regulatory bodies. For instance, in April 2022, Ambu, a Danish medical equipment manufacturer, has introduced the aScope Gastro, which is the world's inaugural sterile single-use gastroscope. This gastroscope boasts advanced imaging capabilities and innovative design elements, making it suitable for a range of endoscopic procedures. Additionally, sterilization is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for reusable products and increasing launch of technologically advanced sterilization devices.
By end-user, hospitals was the highest revenue-grossing segment in the global therapeutic endoscopy devices market in 2023 owing to the surge in the number of patient admissions to hospitals, growing adoption of advanced equipment such as laser devices & Light-Emitting Diodes (LEDs) to provide these therapies in a safe and regulated manner, rising number of endoscopic procedures performed within hospitals, and increasing initiatives by leading market players. For instance, in April 2023, Cook Medical has been awarded a contract by Vizient, a healthcare performance improvement company, to supply endoscopic instruments. Cook Medical intends to utilize this agreement to enhance the accessibility of its endoscopic solutions to medical professionals and patients throughout the United States. Additionally, ambulatory surgical centres is predicted to grow at fastest CAGR during the forecast period owing to the lower costs & patient out-of-pocket charges, and increasing adoption of technologically advanced devices.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of minimal invasive surgeries, growing initiations by government, and rising approvals by regulatory bodies. For instance, in February 2022, EvoEndo, Inc. ('EvoEndo'), has announced that the EvoEndo Single-Use Endoscopy System has obtained FDA 510(k) clearance. The EvoEndo System eliminates the need for general anesthesia or conscious sedation during typical upper endoscopic procedures. This approval follows EvoEndo's distribution agreement with Micro-Tech Endoscopy USA, Inc. ('Micro-Tech'), which will initiate a gradual rollout of the EvoEndo System in hospitals and ASCs across the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the presence of leading market players, increasing research & development activities, and surge in launch of advanced products. For instance, in January 2023, Fujifilm has unveiled the ClutchCutter and FushKnife as the latest additions to their endoscopic solution lineup. These two new products were presented by the company during the 63rd Annual Conference of the Indian Society of Gastroenterology-ISGCON in Jaipur. The ClutchCutter is a rotating forceps designed to aid clinicians in making incisions, performing dissections, and facilitating coagulation. This solution features serrated jaws for better grip and durability, thanks to its insulated outer edge.
Increasing regulatory approvals of advanced endoscopy systems is predicted to boost the market growth during the forecast period. For instance, in July 2022, Zsquare, a prominent developer of high-performance disposable endoscopes, has received FDA 510K clearance for the introduction of its inaugural device, the Zsquare ENT-FlexTM Rhinolaryngoscope. Zsquare plans to initiate a trial program in leading U.S. hospitals and medical practices by the fourth quarter of 2022. Notably, the Zsquare ENT-FlexTM endoscope stands out as the first to incorporate a hybrid design, featuring an entirely disposable optical shell that encompasses a reusable imaging core.
By product, endoscope was the highest revenue-grossing segment in the global therapeutic endoscopy devices market in 2023 owing to yhe high resolution & high-quality images delivered by endoscopes for diagnosis & treatment of various diseases, rising investment for the development of technologically advanced endoscopy methods such as capsule endoscopes, duodenoscopes & echoendoscopes, and increasing approvals by regulatory bodies. For instance, in May 2023, Olympus Corporation, a global leader in developing and providing innovative solutions for medical and surgical procedures, has disclosed the FDA's clearance for their latest EVIS X1 endoscopy system and two corresponding gastrointestinal endoscopes. The GIF-1100 gastrointestinal videoscopes are recommended for examining the upper digestive tract, encompassing the esophagus, stomach, and duodenum. Additionally, endoscopy visualization systems is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for minimally invasive procedures, increasing prevalence of diseases, and surge in adoption of advanced products.
By hygiene, single use was the highest revenue-grossing segment in the global therapeutic endoscopy devices market in 2023 owing to the safety of patients has improved with the introduction of disposable endoscopes, increasing adoption of disposable products due to rising concerns regarding contamination & infections, and surge in approvals by regulatory bodies. For instance, in April 2022, Ambu, a Danish medical equipment manufacturer, has introduced the aScope Gastro, which is the world's inaugural sterile single-use gastroscope. This gastroscope boasts advanced imaging capabilities and innovative design elements, making it suitable for a range of endoscopic procedures. Additionally, sterilization is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for reusable products and increasing launch of technologically advanced sterilization devices.
By end-user, hospitals was the highest revenue-grossing segment in the global therapeutic endoscopy devices market in 2023 owing to the surge in the number of patient admissions to hospitals, growing adoption of advanced equipment such as laser devices & Light-Emitting Diodes (LEDs) to provide these therapies in a safe and regulated manner, rising number of endoscopic procedures performed within hospitals, and increasing initiatives by leading market players. For instance, in April 2023, Cook Medical has been awarded a contract by Vizient, a healthcare performance improvement company, to supply endoscopic instruments. Cook Medical intends to utilize this agreement to enhance the accessibility of its endoscopic solutions to medical professionals and patients throughout the United States. Additionally, ambulatory surgical centres is predicted to grow at fastest CAGR during the forecast period owing to the lower costs & patient out-of-pocket charges, and increasing adoption of technologically advanced devices.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of minimal invasive surgeries, growing initiations by government, and rising approvals by regulatory bodies. For instance, in February 2022, EvoEndo, Inc. ('EvoEndo'), has announced that the EvoEndo Single-Use Endoscopy System has obtained FDA 510(k) clearance. The EvoEndo System eliminates the need for general anesthesia or conscious sedation during typical upper endoscopic procedures. This approval follows EvoEndo's distribution agreement with Micro-Tech Endoscopy USA, Inc. ('Micro-Tech'), which will initiate a gradual rollout of the EvoEndo System in hospitals and ASCs across the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the presence of leading market players, increasing research & development activities, and surge in launch of advanced products. For instance, in January 2023, Fujifilm has unveiled the ClutchCutter and FushKnife as the latest additions to their endoscopic solution lineup. These two new products were presented by the company during the 63rd Annual Conference of the Indian Society of Gastroenterology-ISGCON in Jaipur. The ClutchCutter is a rotating forceps designed to aid clinicians in making incisions, performing dissections, and facilitating coagulation. This solution features serrated jaws for better grip and durability, thanks to its insulated outer edge.
Segmentation: Therapeutic Endoscopy Devices Market Report 2022 - 2033
Therapeutic Endoscopy Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Mechanical Endoscopic Equipment
- Endoscope
- Rigid Endoscopy Devices
- Capsule Endoscopy Devices
- Flexible Endoscopy Devices
- Robot-Assisted Endoscopy Devices
- Disposable Endoscopy Devices
- Endoscopy Visualization Systems
Therapeutic Endoscopy Devices Market Analysis & Forecast by Hygiene 2023 - 2034 (Revenue USD Bn)
- Reprocessing
- Single Use
- Sterilization
Therapeutic Endoscopy Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Ambulatory Surgical Centers
- Hospitals
- Others
Therapeutic Endoscopy Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Therapeutic Endoscopy Devices Market: Product Estimates & Trend Analysis
8. Therapeutic Endoscopy Devices Market: Hygiene Estimates & Trend Analysis
9. Therapeutic Endoscopy Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Therapeutic Endoscopy Devices Market
12. Europe Global Therapeutic Endoscopy Devices Market
13. Asia Pacific Global Therapeutic Endoscopy Devices Market
14. Latin America Global Therapeutic Endoscopy Devices Market
15. MEA Global Therapeutic Endoscopy Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Karl Storz GmbH & Co. KG
- Ethicon Endo-surgery LLC.
- Medtronic Plc (Covidien)
- FUJIFILM Holdings Corporation
- Olympus Corporation
- Stryker Corporation
- Richard Wolf GmbH
- PENTAX Medical
- Boston Scientific Corporation
- Machida Endoscope Co. Ltd.
- Zsquare
- Smith & Nephew Inc.
- Ambu Inc.
- Cook Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.68 Billion |
| Forecasted Market Value ( USD | $ 5.86 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
